# Selank withdrawal: alcohol, morphine, and dependence research > Selank withdrawal research: what rodent studies show on alcohol and morphine withdrawal, plus why users report no dependence. Cited, research context only. Two questions, kept apart: does Selank itself cause withdrawal, and could it help with withdrawal from other substances? The studies answer differently. ## The short version **Selank withdrawal** actually means two different things, and it's worth not mixing them up. The first question is whether Selank itself is addictive or causes a withdrawal crash when you stop. The second is whether Selank might *help* with withdrawal from other substances, like alcohol or opioids. On the first: the research and the user reports point the same way — Selank is not described as causing dependence, tolerance, or a withdrawal syndrome, which is one of its main selling points versus benzodiazepines [6]. That said, the long-term human data simply don't exist yet. On the second: this is genuinely a research direction. In rodents, Selank reduced anxiety during alcohol withdrawal [8] and eased the aversive signs of morphine withdrawal [11]. Those are animal findings — promising, not proven in people. Both threads are unpacked below. ## Does Selank itself cause withdrawal? The whole reason Selank drew interest is that it appears to break the usual trade-off. The Russian clinical study in generalized anxiety disorder reported an anxiolytic effect comparable to a benzodiazepine but with a tolerability profile free of the sedation, cognitive impairment, and *withdrawal* those drugs cause [6]. Mechanistically this fits: Selank modulates GABA rather than forcing it like a benzodiazepine [1], so it doesn't appear to drive the receptor adaptations that produce physical dependence. User reports echo this — people commonly say they don't hit tolerance escalation, rebound anxiety, or a withdrawal syndrome when they stop. But that absence-of-dependence picture rests on short-term and anecdotal experience, not long human safety trials, so the long-term story is not established, and psychological reliance on anything that reliably calms anxiety is still possible. ## Selank in alcohol withdrawal models This is where Selank's withdrawal research is most developed. In a rat model of alcohol withdrawal syndrome, Selank reduced the withdrawal-associated anxiety-like behavior in animals with stable alcoholic motivation [8]. The anxiety spike that drives relapse is exactly the symptom a non-sedating anxiolytic might address. The related ethanol work fills in the picture. Selank inhibited ethanol-induced hyperlocomotion and behavioral sensitization in DBA/2 mice [9], and in a separate study it protected against ethanol-induced memory impairment in rats [10]. Together these suggest Selank can blunt several of alcohol's behavioral and cognitive effects in animals — a coherent preclinical case, though still confined to rodents. ## Selank in opioid (morphine) withdrawal The opioid-withdrawal angle is the newest thread in this digest. In the most recent study summarized here (2022), Selank — a peptide analog of tuftsin — attenuated the aversive signs of morphine withdrawal syndrome in rats [11]. There's a mechanistic reason this isn't surprising: Selank inhibits the enzymes that break down enkephalins, the body's own opioid-like peptides [2]. By stabilizing endogenous opioid signaling without being an opioid itself, it could plausibly soften the rebound that withdrawal produces. As with the alcohol work, this is an animal finding — a research direction, not a demonstrated human treatment for opioid withdrawal. ## How does Selank differ from benzodiazepines here? The contrast is the whole point. Benzodiazepines calm anxiety but carry a well-known dependence and withdrawal liability — and benzodiazepine withdrawal itself can be severe. Selank, in the clinical record, produced comparable anxiety relief without that dependence signal [6], and works by modulating GABA allosterically rather than acting as a direct sedative [1]. Interestingly, the two aren't strictly either-or in research: in an unpredictable chronic mild stress model, diazepam combined with Selank was the most effective intervention, restoring behavior toward pre-stress levels [7]. That hints at a complementary GABAergic interaction in animals — though, again, this is preclinical and not a basis for any human protocol. ## Reading the withdrawal research honestly The withdrawal evidence for Selank is almost entirely rodent work from Russian groups [8][11], and it has not been replicated as human addiction-treatment trials. It is a legitimately interesting research direction — a non-sedating, non-dependence-forming anxiolytic that eases withdrawal anxiety in animals — but "interesting in rats" is the start of the story, not the verdict. Selank is not an approved treatment for any substance-use disorder. For the full mechanism see [Selank research](/research); for safety context see [Selank effects](/effects); every study is listed on [Selank references](/references). --- A friendly, honestly-cited digest of the Selank research — bright on the page, careful with the evidence.